Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Oct 16, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | PROK | ProKidney Corp. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $439.9M | 740.3K | 784.3K | 94.4% |
| 2 | AURA | Aura Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $657.5M | 246.1K | 270.5K | 91.0% |
| 3 | GNLX | Genelux Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $112.2M | 132.8K | 147.3K | 90.1% |
| 4 | TYRA | Tyra Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.31B | 140.7K | 158.8K | 88.6% |
| 5 | ANRO | Alto Neuroscience Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $887.7M | 205.6K | 234.0K | 87.9% |
| 6 | BIVI | BioVie Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $9.8M | 121.3K | 139.0K | 87.3% |
| 7 | LBRX | LB Pharmaceuticals Inc | Health CareBiotechnology: Pharmaceutical Preparations | $1.18B | 247.1K | 283.2K | 87.3% |
| 8 | VCEL | Vericel Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.10B | 231.1K | 266.9K | 86.6% |
| 9 | TLSI | TriSalus Life Sciences Inc. | Health CareMedical Specialities | $240.1M | 88.6K | 102.8K | 86.3% |
| 10 | CNTN | Canton Strategic Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $149.0M | 462.0K | 537.1K | 86.0% |
| 11 | AVBP | ArriVent BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $827.9M | 415.9K | 484.9K | 85.8% |
| 12 | MANE | Veradermics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $4.81B | 290.2K | 338.8K | 85.7% |
| 13 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $4.32B | 222.8K | 260.7K | 85.5% |
| 14 | KMTS | Kestra Medical Technologies Ltd. | Health CareMedical/Dental Instruments | $1.71B | 105.3K | 123.3K | 85.4% |
| 15 | SRRK | Scholar Rock Holding Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.95B | 1.10M | 1.29M | 85.1% |
| 16 | NYXH | Nyxoah SA | Health CareMedical/Dental Instruments | $119.1M | 115.6K | 136.9K | 84.4% |
| 17 | OGI | Organigram Global Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $131.4M | 146.6K | 175.1K | 83.7% |
| 18 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.48B | 126.1K | 150.9K | 83.5% |
| 19 | SYRE | Spyre Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.36B | 347.5K | 417.7K | 83.2% |
| 20 | MDLN | Medline Inc. | Health CareMedical/Dental Instruments | $48.08B | 2.60M | 3.13M | 83.1% |
| 21 | HRMY | Harmony Biosciences Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.23B | 355.1K | 429.2K | 82.7% |
| 22 | AORT | Artivion Inc. | Health CareMedical/Dental Instruments | $1.07B | 151.5K | 185.2K | 81.8% |
| 23 | RLMD | Relmada Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $341.3M | 320.1K | 391.6K | 81.8% |
| 24 | FDMT | 4D Molecular Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $711.0M | 182.5K | 224.1K | 81.5% |
| 25 | RMD | ResMed Inc. | Health CareMedical/Dental Instruments | $34.07B | 511.9K | 629.9K | 81.3% |
| 26 | ANL | Adlai Nortye Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $778.6M | 122.6K | 151.7K | 80.8% |
| 27 | IRON | Disc Medicine Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.17B | 160.0K | 198.0K | 80.8% |
| 28 | IPEX | Inflection Point Acquisition Corp. V | Health CareBiotechnology: Pharmaceutical Preparations | - | 256.7K | 317.8K | 80.8% |
| 29 | COGT | Cogent Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.12B | 896.1K | 1.11M | 80.6% |
| 30 | SGMT | Sagimet Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $576.3M | 284.5K | 354.7K | 80.2% |
| 31 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.66B | 189.8K | 238.5K | 79.6% |
| 32 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $12.07B | 149.3K | 187.6K | 79.6% |
| 33 | SGRY | Surgery Partners Inc. | Health CareHospital/Nursing Management | $1.93B | 184.5K | 232.1K | 79.5% |
| 34 | STTK | Shattuck Labs Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $555.0M | 166.9K | 210.0K | 79.5% |
| 35 | CLDX | Celldex Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.27B | 278.4K | 350.9K | 79.3% |
| 36 | SNDA | Sonida Senior Living Inc. | Health CareHospital/Nursing Management | $1.72B | 124.9K | 157.8K | 79.2% |
| 37 | NGNE | Neurogene Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $479.3M | 167.1K | 211.2K | 79.1% |
| 38 | BBNX | Beta Bionics Inc. | Health CareMedical/Dental Instruments | $911.2M | 133.3K | 168.6K | 79.0% |
| 39 | DSGN | Design Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $655.9M | 217.7K | 275.5K | 79.0% |
| 40 | PLX | Protalix BioTherapeutics Inc. (DE) | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $217.5M | 342.9K | 435.4K | 78.8% |
| 41 | ESTA | Establishment Labs Holdings Inc. | Health CareIndustrial Specialties | $1.83B | 94.1K | 119.5K | 78.7% |
| 42 | SLDB | Solid Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $615.5M | 339.6K | 431.8K | 78.7% |
| 43 | ICLR | ICON plc | Health CareBiotechnology: Commercial Physical & Biological Resarch | $13.41B | 186.7K | 238.2K | 78.4% |
| 44 | BTSG | BrightSpring Health Services Inc. | Health CareMedical/Nursing Services | $12.34B | 542.1K | 692.0K | 78.3% |
| 45 | PRGO | Perrigo Company plc | Health CareBiotechnology: Pharmaceutical Preparations | $2.29B | 687.9K | 880.2K | 78.1% |
| 46 | CGEM | Cullinan Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $901.0M | 392.3K | 502.5K | 78.1% |
| 47 | ZLAB | Zai Lab Limited | Health CareBiotechnology: Pharmaceutical Preparations | $2.64B | 184.0K | 235.9K | 78.0% |
| 48 | MPLT | MapLight Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $519.5M | 83.5K | 107.1K | 77.9% |
| 49 | NEO | NeoGenomics Inc. | Health CarePrecision Instruments | $2.22B | 464.9K | 597.0K | 77.9% |
| 50 | OVID | Ovid Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $441.4M | 275.9K | 354.6K | 77.8% |
| 51 | MBX | MBX Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.44B | 261.3K | 336.8K | 77.6% |
| 52 | BIIB | Biogen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $34.77B | 423.8K | 546.8K | 77.5% |
| 53 | GKOS | Glaukos Corporation | Health CareMedical/Dental Instruments | $9.77B | 270.8K | 349.6K | 77.5% |
| 54 | NVST | Envista Holdings Corporation | Health CareMedical/Dental Instruments | $3.77B | 622.6K | 804.1K | 77.4% |
| 55 | MESO | Mesoblast Limited | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.81B | 206.3K | 267.1K | 77.3% |
| 56 | SRZN | Surrozen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $294.7M | 91.1K | 118.2K | 77.0% |
| 57 | SNN | Smith & Nephew SNATS Inc. | Health CareIndustrial Specialties | $12.18B | 327.9K | 428.2K | 76.6% |
| 58 | HRTX | Heron Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $71.5M | 746.0K | 979.4K | 76.2% |
| 59 | ACHV | Achieve Life Sciences Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $717.2M | 616.7K | 810.9K | 76.1% |
| 60 | VIR | Vir Biotechnology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.79B | 443.9K | 585.5K | 75.8% |
| 61 | RDNT | RadNet Inc. | Health CareMedical Specialities | $5.54B | 106.9K | 141.0K | 75.8% |
| 62 | MMSI | Merit Medical Systems Inc. | Health CareMedical/Dental Instruments | $5.35B | 180.1K | 237.8K | 75.7% |
| 63 | ELTX | Elicio Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $48.2M | 112.1K | 148.2K | 75.6% |
| 64 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 366.4K | 485.4K | 75.5% |
| 65 | OCUL | Ocular Therapeutix Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.62B | 737.2K | 977.9K | 75.4% |
| 66 | ATRC | AtriCure Inc. | Health CareMedical/Dental Instruments | $2.94B | 176.3K | 234.7K | 75.1% |
| 67 | AVR | Anteris Technologies Global Corp. | Health CareIndustrial Specialties | $619.8M | 310.7K | 413.9K | 75.1% |
| 68 | EIKN | Eikon Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $408.4M | 161.0K | 214.6K | 75.0% |
| 69 | IBIO | iBio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $97.0M | 120.7K | 161.4K | 74.8% |
| 70 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.99B | 119.0K | 159.2K | 74.8% |
| 71 | ABUS | Arbutus Biopharma Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $657.6M | 784.2K | 1.05M | 74.7% |
| 72 | PTGX | Protagonist Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.84B | 278.3K | 372.5K | 74.7% |
| 73 | OGN | Organon & Co. | Health CareBiotechnology: Pharmaceutical Preparations | $3.61B | 607.6K | 815.0K | 74.6% |
| 74 | LCTX | Lineage Cell Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $250.5M | 561.0K | 755.0K | 74.3% |
| 75 | GENB | Generate Biomedicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.68B | 347.8K | 468.5K | 74.3% |
| 76 | JBIO | Jade Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $875.1M | 253.2K | 341.6K | 74.1% |
| 77 | RAPP | Rapport Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.42B | 103.8K | 140.1K | 74.1% |
| 78 | TSHA | Taysha Gene Therapies Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.22B | 614.8K | 837.5K | 73.4% |
| 79 | AXGN | Axogen Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.09B | 290.6K | 396.5K | 73.3% |
| 80 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 81 | STOK | Stoke Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.59B | 207.7K | 283.7K | 73.2% |
| 82 | SABS | SAB Biotherapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $235.7M | 249.9K | 341.4K | 73.2% |
| 83 | ABEO | Abeona Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $265.9M | 261.9K | 358.0K | 73.2% |
| 84 | SHC | Sotera Health Company | Health CareMisc Health and Biotechnology Services | $5.16B | 338.1K | 462.3K | 73.1% |
| 85 | UPXI | Upexi Inc. | Health Care Medicinal Chemicals and Botanical Products | $93.5M | 794.2K | 1.09M | 73.0% |
| 86 | NEOG | Neogen Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.68B | 450.6K | 620.2K | 72.6% |
| 87 | AGIO | Agios Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.93B | 207.3K | 286.2K | 72.4% |
| 88 | IRTC | iRhythm Holdings Inc. | Health CareMedical/Dental Instruments | $3.60B | 136.6K | 188.8K | 72.3% |
| 89 | IRD | Opus Genetics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $336.9M | 885.7K | 1.22M | 72.3% |
| 90 | LTRN | Lantern Pharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $10.0M | 152.4K | 211.0K | 72.2% |
| 91 | SVRA | Savara Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $973.9M | 495.7K | 689.1K | 71.9% |
| 92 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $22.96B | 388.2K | 540.5K | 71.8% |
| 93 | RYTM | Rhythm Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.06B | 97.8K | 136.3K | 71.7% |
| 94 | WHWK | Whitehawk Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $173.3M | 78.4K | 109.4K | 71.7% |
| 95 | NVCR | NovoCure Limited | Health CareMedical/Dental Instruments | $1.68B | 373.1K | 520.8K | 71.6% |
| 96 | TFX | Teleflex Incorporated | Health CareMedical/Dental Instruments | $5.43B | 210.8K | 294.5K | 71.6% |
| 97 | ULS | UL Solutions Inc. | Health CarePrecision Instruments | $15.02B | 437.6K | 611.3K | 71.6% |
| 98 | BVS | Bioventus Inc. | Health CareMedical/Dental Instruments | $1.16B | 83.8K | 117.3K | 71.4% |
| 99 | PRAX | Praxis Precision Medicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.93B | 134.0K | 187.7K | 71.4% |
| 100 | HYPR | Hyperfine Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $82.7M | 247.0K | 346.9K | 71.2% |